Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Iot symbols : Xbit save search
XBiotech Announces First Patient Enrolled in Phase I Clinical Trial for Novel Arthritis Therapy Natrunix-SQ
Published: 2022-01-26 (Crawled : 15:00) - globenewswire.com
XBIT | $7.98 0.89% 0.88% 76K
|
Health Technology
|
| O: 0.28%
H: 3.63%
C: -2.51%
trial therapy biotech iot enroll
FDA Approves XBiotech’s IND in RheumatologyLaunching Novel True Human Antibody Therapy Natrunix™ to Treat Rheumatology
Published: 2021-12-13 (Crawled : 14:30) - biospace.com/
XBIT | $7.98 0.89% 0.88% 76K
|
Health Technology
|
| O: -1.37%
H: 0.0%
C: 0.0%
fda therapy antibody biotech iot
XBiotech to Launch Novel Candidate Therapy for StrokeCompany Commencing Phase I/II Study to Test Safety and Efficacy of its New Drug Candidate to Reduce Brain Injury After Stroke
Published: 2021-10-28 (Crawled : 18:00) - biospace.com/
XBIT | $7.98 0.89% 0.88% 76K
|
Health Technology
|
| O: 0.56%
H: 4.35%
C: 0.7%
new drug stroke test therapy biotech drug iot train
XBiotech to Launch Novel Candidate Therapy for Stroke
Published: 2021-10-28 (Crawled : 17:00) - globenewswire.com
XBIT | $7.98 0.89% 0.88% 76K
|
Health Technology
|
| O: 0.56%
H: 4.35%
C: 0.7%
stroke therapy biotech iot
Dr. Benjamin Musher to Chair Phase 1-2 Study Evaluating XBiotech’s Natrunix™ Anti-Cancer Therapy in Pancreatic Cancer
Published: 2021-09-08 (Crawled : 14:00) - biospace.com/
XBIT | $7.98 0.89% 0.88% 76K
|
Health Technology
|
| O: 0.25%
H: 0.89%
C: -0.44%
phase 1 therapy cancer biotech iot pancreatic phase 2 phase 3 pancreas
XBiotech Announces Addition of Dr. Mark Ziats, M.D. Ph.D. as Medical Director
Published: 2021-08-30 (Crawled : 14:00) - biospace.com/
XBIT | $7.98 0.89% 0.88% 76K
|
Health Technology
|
| O: -0.81%
H: 2.25%
C: 1.31%
biotech iot
XBiotech Announces Payment of Dividend to Holders of Common Stock
Published: 2021-07-30 (Crawled : 15:15) - globenewswire.com
XBIT | $7.98 0.89% 0.88% 76K
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
biotech iot
XBiotech Announces Dividend to Holders of Common Stock
Published: 2021-07-06 (Crawled : 21:00) - globenewswire.com
XBIT | $7.98 0.89% 0.88% 76K
|
Health Technology
|
| O: 9.28%
H: 2.51%
C: -1.71%
biotech iot
XBiotech Announces Receipt of $75 Million from Sale of Antibody
Published: 2021-06-30 (Crawled : 16:00) - globenewswire.com
XBIT | $7.98 0.89% 0.88% 76K
|
Health Technology
|
| O: -0.24%
H: 4.3%
C: 0.3%
antibody biotech iot sales
XBiotech Announces First Patient Enrolled in Clinical Trial Evaluating XB2001 for the Treatment of Pancreatic Cancer
Published: 2021-06-23 (Crawled : 13:00) - globenewswire.com
XBIT | $7.98 0.89% 0.88% 76K
|
Health Technology
|
| O: -0.12%
H: 1.73%
C: 1.17%
treatment cancer biotech iot trial pancreatic pancreas enroll
FDA Gives Go-Ahead for XBiotech’s Candidate Therapy for Phase I/II Double-blind Placebo Controlled Study in Pancreatic CancerXBiotech’s New Drug to Enter Clinical Studies in Combination Therapy for Pancreatic Cancer
Published: 2021-04-19 (Crawled : 10:00) - biospace.com/
XBIT | $7.98 0.89% 0.88% 76K
|
Health Technology
|
| O: 4.1%
H: 0.0%
C: -4.23%
new drug fda therapy cancer biotech drug iot pancreatic pancreas
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.